目前市值2.2亿,即使以2018年最高的0.22亿净利润计算,市盈率也达到了10,缺乏吸引力。查看全文
平凡Stone2021-02-03 23:06
$Kamada(KMDA)$ ARK fund Israel
Kamada Ltd.是一家通过销售市场现有罕见组合药物产品的,等离子体衍生蛋白质疗法公司。公司开发和生产的专业衍化蛋白质疗法产品,在一些新兴市场上,这些产品通过美洲和欧洲的战略合作伙伴被经营出售,或者通过当地的经销商直接在当地销售,该公司的旗舰产品是“...查看全文
一年交易一次2020-02-06 07:39
$Kamada(KMDA)$ Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, today announced that it will release financial results for the fourth quarter and fiscal year ended December 31, 2019, prior to the open of the U.S. financial markets on Wedne...查看全文
$Kamada(KMDA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-039478 Act: 34 Size: 22 KB 网页链接
$Kamada(KMDA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-037421 Act: 34 Size: 27 KB 网页链接
$Kamada(KMDA)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001213900-22-035395 Act: 33 Size: 116 KB 网页链接
$Kamada(KMDA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-032911 Act: 34 Size: 22 KB 网页链接
$Kamada(KMDA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-030575 Act: 34 Size: 25 KB 网页链接
$Kamada(KMDA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-027413 Act: 34 Size: 439 KB 网页链接
$Kamada(KMDA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-027411 Act: 34 Size: 26 KB 网页链接
$Kamada(KMDA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-025367 Act: 34 Size: 22 KB 网页链接
$Kamada(KMDA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-021536 Act: 34 Size: 20 KB 网页链接
$Kamada(KMDA)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001213900-22-012308 Act: 34 Size: 14 MB 网页链接